New Horizon Aircraft Ltd. (NASDAQ: HOVR) will raise approximately $20 million in gross proceeds through an offering of 9,254,889 Class A ordinary shares to a group of institutional investors.
"This financing reflects strong recognition of the strategic importance of Horizon Aircraft's cutting-edge aerospace development," Brandon Robinson, CEO of Horizon Aircraft, said in a statement. "We are now equipped to enhance our ability to develop world-class innovative technologies, accelerate our commercialization timeline, and attract and retain elite talent."
The offering, expected to close on or about May 8, 2026, will provide net proceeds to fund and accelerate the development of the company's Cavorite X7 aircraft program, with the remainder intended for working capital and general corporate purposes. Titan Partners is acting as the sole placement agent for the offering, which is being made under a previously filed Form S-3 shelf registration statement.
The capital raise follows a 91 percent rally in the company's stock year-to-date, giving it a market capitalization of approximately $103 million. The new share issuance will increase the number of outstanding shares, creating potential dilution for existing shareholders. This offering is significantly larger than previous capital raises, which included a $2.9 million public offering in August 2024 and a combined $11.1 million from a strategic investment and warrant exercises around January 2025.
Cavorite X7 Development
Horizon Aircraft is an advanced aerospace company developing a hybrid-electric Vertical Takeoff and Landing (VTOL) aircraft. Its Cavorite X7 is designed to fly most of its mission in a traditional wing-borne configuration, which the company says will offer industry-leading speed and range. The company holds more cash than debt and has a current ratio of 14.81, indicating a strong short-term liquidity position before this new infusion of capital.
The successful closing of this $20 million financing is a critical step for the pre-revenue company to advance its Cavorite X7 aircraft toward certification and commercial production. However, investors will be weighing the accelerated development timeline against the significant share dilution, especially following the stock's recent run-up. The market's reaction after the closing on May 8 will be a key test of investor confidence in the company's long-term strategy.
This article is for informational purposes only and does not constitute investment advice.